These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparison of Intralesional Sodium Stibogluconate versus Intralesional Meglumine Antimoniate for the Treatment of Leishmania major Cutaneous Leishmaniasis. Solomon M, Ollech A, Pavlotsky F, Barzilai A, Schwartz E, Baum S, Astman N. Acta Derm Venereol; 2024 Apr 29; 104():adv35089. PubMed ID: 38682801 [Abstract] [Full Text] [Related]
4. Efficacy of CO(2) laser for treatment of anthroponotic cutaneous leishmaniasis, compared with combination of cryotherapy and intralesional meglumine antimoniate. Shamsi Meymandi S, Zandi S, Aghaie H, Heshmatkhah A. J Eur Acad Dermatol Venereol; 2011 May 29; 25(5):587-91. PubMed ID: 20666876 [Abstract] [Full Text] [Related]
7. Clinical efficacy of intramuscular meglumine antimoniate alone and in combination with intralesional meglumine antimoniate in the treatment of old world cutaneous leishmaniasis. Munir A, Janjua SA, Hussain I. Acta Dermatovenerol Croat; 2008 May 29; 16(2):60-4. PubMed ID: 18541100 [Abstract] [Full Text] [Related]
8. The therapeutic effect of combined cryotherapy, paramomycin, and intralesional meglumine antimoniate in treating lupoid leishmaniasis and chronic leishmaniasis. Nilfrousihzadeh MA, Jaffray F, Reiszadeh MR, Ansari N. Int J Dermatol; 2006 Aug 29; 45(8):989-91. PubMed ID: 16911395 [No Abstract] [Full Text] [Related]
11. Comparison of intralesionally injected zinc sulfate with meglumine antimoniate in the treatment of acute cutaneous leishmaniasis. Iraji F, Vali A, Asilian A, Shahtalebi MA, Momeni AZ. Dermatology; 2004 Aug 29; 209(1):46-9. PubMed ID: 15237267 [Abstract] [Full Text] [Related]
12. Treatment of cutaneous leishmaniasis with either topical paromomycin or intralesional meglumine antimoniate. Faghihi G, Tavakoli-kia R. Clin Exp Dermatol; 2003 Jan 29; 28(1):13-6. PubMed ID: 12558620 [Abstract] [Full Text] [Related]
13. Generic sodium stibogluconate is as safe and effective as branded meglumine antimoniate, for the treatment of tegumentary leishmaniasis in Isiboro Secure Park, Bolivia. Bermúdez H, Rojas E, Garcia L, Desjeux P, Dujardin JC, Boelaert M, Chappuis F. Ann Trop Med Parasitol; 2006 Oct 29; 100(7):591-600. PubMed ID: 16989685 [Abstract] [Full Text] [Related]
17. Cutaneous leishmaniasis in a patient receiving infliximab for psoriatic arthritis: treatment with cryotherapy and intralesional meglumine antimonate. Català A, Barnadas MA, Muñoz C, Puig L. Actas Dermosifiliogr; 2014 Sep 29; 105(7):714-6. PubMed ID: 24275564 [No Abstract] [Full Text] [Related]
18. Allopurinol in the treatment of American cutaneous leishmaniasis. Martinez S, Marr JJ. N Engl J Med; 1992 Mar 12; 326(11):741-4. PubMed ID: 1738379 [Abstract] [Full Text] [Related]
19. Comparison of lesion improvement in lupoid leishmaniasis patients with two treatment approaches: trichloroacetic Acid and intralesional meglumine antimoniate. Banihashemi M, Yazdanpanah MJ, Amirsolymani H, Yousefzadeh H. J Cutan Med Surg; 2015 Mar 12; 19(1):35-9. PubMed ID: 25775661 [Abstract] [Full Text] [Related]
20. Intralesional treatment of cutaneous leishmaniasis with meglumine antimoniate. Aste N, Pau M, Ferreli C, Biggio P. Br J Dermatol; 1998 Feb 12; 138(2):370-1. PubMed ID: 9602904 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]